Associations of NPI-Q-Assessed SD and Vascular Risk With Prospective Cognitive Decline Controlling for CSF AD Biomarkers (CSF-Aβ, CSF-Tau, and CSF-Ptau) and Hippocampal Volume. Here, MAPT is linked to Alzheimer disease.